News 2012
December 2012:
Ensymm is demanded for a BP preparation and further consulting in order to establish a medical startup company in Germany.
Ensymm delivers a full set of 20 kW solar panel systems to MENA – turnkey “made in Germany”.
Ensymm delivers xylanase on regular basis from India to Germany for paper and feed industry.
November 2012:
Ensymm submits a blood bag plant BP to a KSA investor along with further support for the financing procedure, such as off-take agreement arrangements.
Ensymm submits a GAP analysis and a related comprehensive report for a biopolymer project to a GCC bio marine company. Based on ensymm marketing report findings, at site inspections and at site coordination, ensymm provides advice for a plant upgrade to reach a higher product standard.
Ensymm and Disolut start exploring the production of medical yeast capsules for EU for diarrhea diseases.
October 2012:
Ensymm arranges an off-take agreement contract successfully in order to support the client along with the preparation of a BP for bank application.
Ensymm delivers, on long term contract based, lactase bulk powder for drop production in Pakistan.
Ensymm delivers IV warmer to a regular client.
September 2012:
Ensymm prepares a project study for a mobile IV solution plant for Solomon Islands.
August 2012:
Ensymm prepares a project study to explore the industrial potential of seaweed and macro algae production.
July 2012:
Ensymm prepares a fully bankable BP for establishing a multi generic pharmaceutical factory in Africa.
June 2012:
Ensymm prepares an IV production BP for a member of the royal family Al-Thani in Qatar.
Ensymm prepares a bankable BP for a KSA investment group for IV solution and blood tube production as a package.
Ensymm transfers the process and technology for invert sugar processing to 3 Indian companies along with regular purchase of related invertase enzyme.
May 2012:
Ensymm prepares a BP for date syrup plant in MENA.
April 2012:
Ensymm delivers on regular base, drops and capsules for lactase intolerant consumers to a South African pharma-company.
March 2012:
Ensymm prepares a BP for an IV solution plant in KSA.
Ensymm prepares an Aloe Vera project study for an Iranian company and signs a consulting contract for establishing an Aloe Vera drink line along with European product license.
February 2012:
Ensymm prepares a Business Plan (BP) for an IV solution plant in Libya.
Ensymm delivers liquid lactase to Italy.
January 2012:
Ensymm signs a process transfer contract for lactase drop production and related enzyme supply in the UK.
Ensymm receives order for a chitosan production project study preparation in Africa.